Eventide Asset Management’s Idexx Laboratories IDXX Stock Holding History

Eventide Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$615K	Buy	1,147 +365	+47%	+$205K	0.01%	227
2026 Q1	$436K	Buy	782 +424	+118%	+$272K	0.01%	226
2025 Q4	$244K	Buy	+358	New	+$244K	﹤0.01%	261
2024 Q4	–	Sell	-188,412	Closed	-$95.2M	–	216
2024 Q3	$95.2M	Buy	188,412 +88	+0%	+$42.8K	1.64%	13
2024 Q2	$91.8M	Sell	188,324 -34,563	-16%	-$17.4M	1.57%	16
2024 Q1	$120M	Sell	222,887 -1,086	-0.5%	-$593K	1.89%	11
2023 Q4	$124M	Sell	223,973 -91	-0%	-$42.7K	2.03%	8
2023 Q3	$98M	Sell	224,064 -16,551	-7%	-$8.25M	1.76%	15
2023 Q2	$121M	Sell	240,615 -17,382	-7%	-$8.33M	2.04%	11
2023 Q1	$129M	Buy	257,997 +248	+0.1%	+$119K	2.37%	7
2022 Q4	$105M	Buy	257,749 +211	+0.1%	+$81.9K	2.07%	10
2022 Q3	$83.9M	Buy	257,538 +238	+0.1%	+$87.4K	1.65%	20
2022 Q2	$90.2M	Sell	257,300 -24,400	-9%	-$9.95M	1.93%	15
2022 Q1	$154M	Hold	281,700	–	–	2.41%	4
2021 Q4	$185M	Hold	281,700	–	–	2.37%	6
2021 Q3	$175M	Buy	281,700 +41,700	+17%	+$28M	2.31%	7
2021 Q2	$152M	Hold	240,000	–	–	2.04%	10
2021 Q1	$117M	Hold	240,000	–	–	1.74%	12
2020 Q4	$120M	Buy	240,000 +39,000	+19%	+$17.5M	1.84%	11
2020 Q3	$79M	Buy	201,000 +25,000	+14%	+$9.24M	1.55%	18
2020 Q2	$58.1M	Buy	176,000 +33,000	+23%	+$9.55M	1.26%	26
2020 Q1	$34.6M	Buy	143,000 +40,100	+39%	+$10.5M	1.12%	34
2019 Q4	$26.9M	Hold	102,900	–	–	0.76%	49
2019 Q3	$28M	Hold	102,900	–	–	0.92%	39
2019 Q2	$28.3M	Buy	+102,900	New	+$25.4M	0.86%	40

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Eventide Asset Management's IDXX Position: Q2 2026 in Review

Eventide Asset Management increased its Idexx Laboratories (IDXX) stake by 47% in Q2 2026, buying an estimated $205K and bringing the position to 1,147 shares worth $615K. The position accounts for 0.01% of the portfolio, ranked #227.

Eventide Asset Management first reported a position in IDXX in Q2 2019 and has held it in 25 quarters since. The position peaked at $185M in Q4 2021. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Eventide Asset Management held 1,147 shares of Idexx Laboratories worth $615K as of Q2 2026.
Eventide Asset Management bought 365 Idexx Laboratories shares in Q2 2026, an estimated $205K.
Idexx Laboratories made up 0.01% of Eventide Asset Management's portfolio in Q2 2026, its #227 holding.
Eventide Asset Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 25 quarters since.
Eventide Asset Management's Idexx Laboratories position peaked at $185M in Q4 2021.
1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.